中国学术期刊网络出版总库入编期刊
CNKI中文期刊全文数据库全文收录期刊
中国核心期刊(遴选)数据库全文收录期刊
万方数据——数字化期刊群收录期刊
中文科技期刊数据库全文收录期刊

主管:陕西省卫生健康委员会
主办:西安心身医学研究所
   西安交通大学第一附属医院
国际标准刊号:ISSN2096—1413
国内统一刊号:CN61—1503/R

口服降糖药与甘精胰岛素联合治疗2型糖尿病的临床效果

张敏英

(西安市阎良区人民医院,陕西 西安,710089)

浏览次数:79次 下载次数:361次

摘要:

目的 探讨口服降糖药与甘精胰岛素联合治疗2型糖尿病的临床效果。方法 选取我院收治的2型糖尿病患者100例为研究对象,分为治疗组和对照组,各50例。对照组患者给予口服降糖药,治疗组患者应用甘精胰岛素联合降糖药。比较两组患者的临床效果。结果 治疗后,两组患者餐后2 h血糖、空腹血糖及糖化血红蛋白水平均低于治疗前,且治疗组明显低于对照组(P<0.05);治疗组患者总有效率为96.00%,明显高于对照组的80.00%(P<0.05);治疗组患者并发症总发生率为 2.00%,显著低于对照组的14.00%(P<0.05)。结论 口服降糖药物联合甘精胰岛素治疗2型糖尿病,临床效果显著,可降低患者血糖,并发症发生率低,值得临床应用推广。

关键词:2 型糖尿病;甘精胰岛素;降糖药

中图分类号:R587.1文献标志码:A文章编号:2096-1413(2017)27-0038-02

    Clinical effect of oral hypoglycemic agents combined with insulin glargine in the treatment of type 2 diabetes mellitus
    ZHANG Min-ying
    (Yanliang District People``s Hospital, Xi``an 710089, China)

    ABSTRACT: Objective To investigate the clinical effect of oral hypoglycemic agents combined with insulin glargine in the treatment of type 2 diabetes mellitus. Methods One hundred type 2 diabetes mellitus patients admitted in our hospital were selected and divided into treatment group and control group, with 50 cases in each group. The control group received oral hypoglycemic agents, and the treatment group accepted oral hypoglycemic agents combined with insulin glargine. The clinical effects of the two groups were compared. Results After treatment, the levels of 2 h postprandial blood glucose, fasting plasma glucose and glycated hemoglobin of the two groups were lower than those before treatment, and those of the treatment group were lower than the control group (P<0.05). The total effective rate of the treatment group was 96.00%, which was higher than 80.00% of the control group (P<0.05). The total incidence rate of complications of the treatment group was 2.00%, which was lower than 14.00% of the control group (P<0.05). Conclusion Oral hypoglycemic agents combined with insulin glargine in the treatment of type 2 diabetes mellitus has significant significant effect. It can reduce the patients`` glucose and has low complication rate, which is worthy of application and promotion in clinic.
    KEYWORDS: type 2 diabetes mellitus; insulin glargine; hypoglycemic agents

    参考文献:
    [1] 韩建武,孙慰军.甘精胰岛素联合瑞格列奈治疗2型糖尿病的疗效 [J].广东医学,2013,34(14):2254-2255.
    [2] 张莹,谢毅娟,孟栋栋,等.预混胰岛素转为基础胰岛素联合口服降糖药治疗2 型糖尿病[J].广东医学,2013,34(4):579-582.
    [3] 刘巧玲,孟云霞,任利群,等.不同胰岛素联合口服降糖药对老年糖尿病患者疗效及生存质量影响的比较[J].实用医学杂志,2012,28(11):1835-1837.
    [4] 刘小兰,章文俊,孟春萍,等.精蛋白锌重组赖脯胰岛素25R联合阿卡波糖治疗口服降糖药血糖控制不佳的老年2 型糖尿病疗效观察 [J].中国全科医学,2010,13(33):3787-3789.
    [5] 刘红丽,王叶菊.甘精胰岛素加口服降糖药治疗2型糖尿病105例临床观察[J].医学综述,2011,17(23):3670-3671.
    [6] 何启胜.甘精胰岛素联合口服降糖药治疗2型糖尿病临床观察[J]. 中华全科医学,2011,9(11):1680-1681.
    [7] 宫雅南,程穗茗,黄淑妍.甘精胰岛素联合口服降糖药治疗老年2型糖尿病疗效观察[J].现代中西医结合杂志,2010,19(2):162-163.

     

上一篇美托洛尔联合胺碘酮治疗心律失常的临床效果

下一篇探析喹诺酮类抗菌药在妇科盆腔炎性疾病临床治疗中的应用